JESUS IBARRA: Open Payments
NPI 1194325266 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,437 in 57 payments from 12 companies in 2025. Trend: 2023 $491 · 2024 $2,920 · 2025 $1,437
Food & beverage: $1,240Education: $198
| Company | Payments | Amount |
|---|---|---|
| Olympus America Inc. | 17 | $468 |
| Astellas Pharma US Inc | 3 | $219 |
| ABBVIE INC. | 8 | $169 |
| Boston Scientific Corporation | 6 | $152 |
| Antares Pharma, Inc. | 10 | $150 |
| Ferring Pharmaceuticals Inc. | 4 | $85 |
| Endo USA, Inc. | 3 | $76 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| IMMUNITYBIO, INC. | 1 | $22 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $20 |
Products named: iTIND System, BOTOX, XYOSTED, SpaceOAR VUE System - 10mL, ADSTILADRIN, AVEED, Rezum Generator, ORGOVYX.
Industry payments across TX — which companies pay providers there.
